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Bruno Manadas1,2, Alexander Wlodawer5, Carlos Faro1,2 & Isaura Simões1,2
The widespread presence of pepsin-like enzymes in eukaryotes together with their relevance in the 
control of multiple biological processes is reflected in the large number of studies published so far for 
this family of enzymes. By contrast, pepsin homologs from bacteria have only recently started to be 
characterized. The work with recombinant shewasin A from Shewanella amazonensis provided the first 
documentation of this activity in prokaryotes. Here we extend our studies to shewasin D, the pepsin 
homolog from Shewanella denitrificans, to gain further insight into this group of bacterial peptidases 
that likely represent ancestral versions of modern eukaryotic pepsin-like enzymes. We demonstrate 
that the enzymatic properties of recombinant shewasin D are strongly reminiscent of eukaryotic 
pepsin homologues. We determined the specificity preferences of both shewasin D and shewasin 
A using proteome-derived peptide libraries and observed remarkable similarities between both 
shewasins and eukaryotic pepsins, in particular with BACE-1, thereby confirming their phylogenetic 
proximity. Moreover, we provide first evidence of expression of active shewasin D in S. denitrificans 
cells, confirming its activity at acidic pH and inhibition by pepstatin. Finally, our results revealed 
an unprecedented localization for a family A1 member by demonstrating that native shewasin D 
accumulates preferentially in the cytoplasm.
Aspartic proteases (APs) of family A1 are found ubiquitously in eukaryotic organisms, whereas the presence 
of genes encoding these enzymes in bacteria was shown to be restricted to only seven species, five from marine 
bacteria and two from plant commensals1. However, that study was only based on analysis of gene sequences and 
did not provide proofs of actual expression of active APs in any bacterial species.
Based on molecular modeling it can be postulated that, similarly to their eukaryotic counterparts, pepsin 
homologs from marine bacteria are bi-lobal and contain two catalytic aspartates organized in the consensus 
sequence motif Asp-Thr/Ser-Gly, followed further downstream by the conserved hydrophobic-hydrophobic-Gly 
sequence, which together form the structural feature known as the psi loop. The hallmark catalytic motifs in 
members of family A1 are usually contained in the sequence Xaa-Xaa-Asp-Xbb-Gly-Xcc, in which Xaa is hydro-
phobic, Xbb is Thr or Ser, and Xcc is Ser, Thr or Ala, although the presence of an alanine residue in Xcc is much 
more common among APs of the retropepsin type (family A2)2,3. Interestingly, all pepsin homologs from marine 
bacteria display an Ala residue in this position in the second consensus motif1, as observed in renin (one of the 
exceptions in family A1). Accordingly, it was expected that these bacterial pepsin homologs would be active at 
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weakly acidic pH, since the shift of an optimal pH to a less acidic range observed in renin and retropepsins has 
been partially attributed to the presence of this residue4. However, our results for recombinant shewasin A, the 
pepsin homolog from Shewanella amazonensis, do not support this assumption since the protease was shown 
to be most active at pH 4, displaying no activity at pH 65, clearly suggesting some variations in its subsite bind-
ing pocket. Indeed, shewasin A displayed properties extraordinarily similar to those of pepsin-type proteases, 
although showing molecular features distinguishable from those of its eukaryotic counterparts, such as the lack 
of both signal peptide and prosegment, as well as the number of cysteine residues and their position within the 
sequence5. All in all, these observations suggest that bacterial pepsin-like APs may represent an ancestral version 
of modern pepsin-like enzymes, probably arising from a gene duplication and fusion event from primordial 
homodimeric APs. In fact, our recent identification of a gene for a single-lobed AP in Rickettsia conorii coding 
for an active enzyme with properties resembling those of retropepsins, where the monomer follows the typical 
fold observed in retropepsins, further corroborates this hypothesis6,7. Since the distinguishing molecular features 
of shewasin A are extended to the other four pepsin homologs from marine bacteria, this raises the questions of 
whether these proteases also share similar enzymatic properties and to what extent the properties of these bacte-
rial pepsins are still reflected in the evolutionarily more recent members of family A1.
To start tackling these questions we expanded our investigations to shewasin D, the pepsin-like homolog 
from Shewanella denitrificans which shares 55% sequence identity with shewasin A. In this work, we describe the 
characterization of the recombinant protease and demonstrate that it has properties very similar to shewasin A. 
Moreover, we determined detailed substrate sequence specificity preferences for both shewasin D and shewasin 
A by a high-throughput profiling approach and clearly confirm common preferences with eukaryotic pepsin-like 
proteases, although subtle differences in subsite binding pockets are anticipated. Additionally, we demonstrate 
that shewasin D is transcribed and translated in vivo and provide experimental evidence that it is mainly localized 
in the cytosol in S. denitrificans.
This work provides first evidence for in vivo expression of a pepsin-like AP in bacteria, confirms an unprec-
edented cytoplasmic localization for a family A1 member, and contributes important insights to further under-
standing the evolutionary diversification undertaken by this important family of enzymes.
Results
Expression, purification, and activity of recombinant shewasin D. The S. denitrificans pepsin homolog 
gene shewasin D was chemically synthesized with codon usage optimized for expression in E. coli (Supplementary 
Fig. S1). The synthetic gene was fused in frame with a N-terminal His-Tag and expressed in E. coli C41 (DE3) strain 
in a soluble form. The purification protocol consisted of three chromatographic steps. First, the soluble fraction of 
cell lysates was applied to a His-Trap HP column loaded with cobalt. The fractions enriched in recombinant shewa-
sin D were pooled, concentrated, and then applied to a size exclusion chromatography column. The obtained eluates 
were further purified by anion exchange chromatography (Fig. 1A). The effectiveness of the purification process 
was monitored by SDS-PAGE and Western blot analysis (Fig. 1B). The molecular mass of recombinant shewasin 
D was determined by analytical size exclusion chromatography under non-denaturing conditions and estimated 
to be ~50 kDa (Fig. 1C). This result is consistent with a monomeric state of recombinant shewasin D (theoretical: 
49025 Da) and is in line with what has been previously demonstrated for shewasin A5.
Next, we tested the proteolytic activity of recombinant shewasin D using five different fluorogenic peptides 
typically used as substrates of APs with different origins. None of the three substrates: a renin substrate Arg-Glu-
(EDANS)-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys-(DABCYL)-Arg, a BACE-1 substrate [MCA-Lys]- 
Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-[Lys-DNP], or [MCA-Lys]-Ala-Leu-Ile-Pro-Ser-Tyr-Lys-Trp-Ser-
[Lys-DNP] was cleaved under the conditions applied. The lack of shewasin D activity towards BACE-1 substrate 
suggests different substrate preferences, despite the sequence similarity and relatively close phylogenetic rela-
tionship of this bacterial pepsin-like AP with mammalian BACE-1 and BACE-21. Interestingly, shewasin D also 
failed to cleave the fluorogenic peptide (MCA)Lys-Leu-His-Pro-Glu-Val-Leu-Phe-Val-Leu-Glu-Lys(DNP), which 
was effectively hydrolyzed by shewasin A5. The only fluorogenic peptide cleaved by recombinant shewasin D was 
(MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP), a substrate widely used to assess proteolytic activity 
of A1 APs. This enzyme displayed maximum activity towards this substrate at pH values between pH 3.5 and 4.0, 
with a drastic decrease in activity of 50% and 70% at pH values 3.0 and 5.0, respectively (Fig. 1D). These results 
confirmed the optimal activity of shewasin D at acidic pH, as expected for a typical pepsin-like AP. Analysis of 
the cleavage products by MS revealed Phe*Phe (*indicates the cleavage site) as the major cleavage site (data not 
shown). The kinetic parameters for the hydrolysis of this model peptide were therefore determined at pH 4 and 
estimated to be Km = 8.67 μM, kcat = 3.51 s−1, and kcat/Km = 4.0 × 105 M−1. s−1. This Km value was very similar to 
that of shewasin A5, but the kcat parameter is significantly enhanced and results in a 72.3-fold higher specificity 
constant (kcat/Km), indicating a higher catalytic efficiency of shewasin D for this substrate. Maximal substrate 
turnover for (MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) was detected between 30 °C and 37 °C. 
Above this temperature the activity abruptly decreased, with no detectable activity remaining at 50 °C. At lower 
temperatures the activity decreased gradually, with the enzyme retaining 30% activity at 10 °C (Fig. 1E).
The effect of class-specific inhibitors on the activity of purified recombinant shewasin D was also evalu-
ated (Fig. 1F). With the exception of pepstatin A, which completely inhibited shewasin D activity (at 1 μM), 
no significant inhibitory effect was observed for any other tested compound. To further demonstrate the 
dependence of the catalytic activity on the conserved aspartate residues we generated a mutant in which the 
aspartate belonging to the first catalytic triad was substituted by an alanine [shewasin D_D37A]. Expression 
and purification were performed under identical conditions as described for wt shewasin D and analysis of the 
purified mutant protein by analytical size-exclusion chromatography confirmed an estimated molecular mass 
of ~50kDa (data not shown). However, no proteolytic activity could be detected when tested with (MCA)
Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) at pH 4.0.
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Specificity profiling with proteome-derived peptide libraries. The activity assays that utilized the 
synthetic fluorogenic substrates suggested some differences in specificity preferences between shewasin D and 
shewasin A. To obtain a more general view, we determined the sequence specificity profile for both recombinant 
shewasins using Proteomic Identification of protease Cleavage Sites (PICS)8,9. This approach is based on the iden-
tification of hundreds of cleaved peptide sequences after incubation with database-searchable, proteome-derived 
peptide libraries, which enables the determination of both prime and nonprime specificity preferences of the 
protease of interest in a single experiment. Two complementary peptide libraries prepared by digestion of 
Figure 1. Purification and characterization of recombinant shewasin D. Wild-type shewasin D was 
produced in E. coli in a soluble form, fused to an N-terminal His-tag. A purification protocol was optimized 
as described in Methods. (A) Anion exchange chromatogram. Purified recombinant shewasin D (dotted lines, 
sample 1) was subsequently used in all characterization assays. (B) SDS-PAGE and Western blot (anti-His) 
analyses of sample 1, panel (A). (C) Analytical SEC of purified recombinant shewasin D. The dots indicate 
the elution volumes of molecular mass markers used for calibration (from left to right: aldolase, 158 kDa; 
conalbumin, 75 kDa; ovalbumin, 43 kDa; carbonic anhydrase, 29 kDa; ribonuclease A, 13.7 kDa). (D) Effect of 
pH on the activity of recombinant shewasin D. Shewasin D was tested for activity using the fluorogenic peptide 
(MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) as substrate; activities were measured by incubating 
shewasin D at 37 °C with buffers between pH 2.5 and pH 5.5 containing 0.1 M NaCl. (E) Effect of temperature 
on the activity of recombinant shewasin D. Activity studies were performed by incubating shewasin D at 
temperatures between 5 and 50 °C, for 8 min, towards the same substrate. (F) Effect of protease inhibitors on the 
activity of recombinant shewasin D. The effect of different compounds was tested using the same fluorogenic 
substrate by preincubating the enzyme with each inhibitor for 8 min at 37 °C. ****P < 0.0001 compared with 
control using one-way ANOVA followed by Tukey’s post hoc test. The error bars represent standard deviation of 
the mean.
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human THP1 cell protein extracts with trypsin or GluC, respectively, were independently incubated with puri-
fied recombinant shewasin D or shewasin A. Selective enrichment and mass spectrometric analysis identified 
1341 C-terminal cleavage products from the tryptic library and 322 C-terminal cleavage products from the GluC 
library for shewasin D, as well as 1262 and 393 C-terminal cleavage products from tryptic and GluC libraries, 
respectively, for shewasin A. Database searches using the WebPICS tool9 inferred the corresponding non-prime 
side products and hence the complete cleavage site sequences. Alignment of the cleavage sites and normalization 
to the natural abundance of each amino acid in the human proteome revealed the specificity profiles of recombi-
nant shewasin D and shewasin A (Fig. 2). Consistent results were obtained for each protease using the two com-
plementary peptide libraries. Interestingly, the PICS specificity profiles of shewasin D and A were very similar. 
Both enzymes accommodated a variety of mostly hydrophobic residues in their substrate binding clefts, with a 
slightly stronger restriction on the non-prime side. Positively ionizable amino acids such as histidine, lysine, and 
arginine, as well as the neutral asparagine and glutamine were underrepresented at positions ranging from P1 to 
P410. At P1, directly preceding the cleaved peptide bond, both proteases strongly preferred leucine and aromatic 
amino acids, such as phenylalanine and tyrosine. Interestingly, aspartate was also clearly overrepresented; how-
ever, at the applied pH this amino acid is likely to be protonated to a significant degree and therefore uncharged. 
Proline was never found in this position, while branched aliphatic amino acids, the neutral amino acids serine, 
threonine, glutamine, asparagine, and positively charged amino acids and the achiral glycine were all underrepre-
sented. On the C-terminal side of the scissile bond in P1′ , both enzymes preferred neutral alanine, phenylalanine, 
valine, and serine. Although other hydrophobic amino acids could be accommodated at this position, leucine 
was underrepresented together with proline, histidine, and arginine. At P2, a strong preference for hydrophobic 
amino acids (leucine, phenylalanine, isoleucine, valine, and methionine) was observed, while charged and neu-
tral amino acids are clearly disfavored, as already found in P1. This trend for the preferential accommodation of 
hydrophobic amino acids and exclusion of charged amino acids was maintained in P2′ , as well as in positions 
more distant from the cleavage site, such as P3. Interestingly, position P3′ appeared to be much less stringent, 
accepting all amino acids except proline. Notably, a clear preference for aspartate and proline was observed in P4′ , 
whereas charged and neutral amino acids were underrepresented in P4.
Given the similar profiles observed for both proteases, the highly different activity towards the peptide (MCA)
Lys-Leu-His-Pro-Glu-Val-Leu-Phe-Val-Leu-Glu-Lys(DNP), which was cleaved by shewasin A at Leu*Phe but not 
by shewasin D, was striking.
To investigate whether PICS data could reveal an indication for the underlying reason, we further analyzed 
the tryptic datasets, where large numbers of cleaved sites were identified for both enzymes. First, we generated 
Figure 2. Shewasin D and shewasin A specificity preferences profiled by PICS. Graphical representation 
of shewasin D (A,C) and shewasin A (B,D) specificity profiles by Heatmaps and IceLogos. Results are from 
Tryptic and GluC peptide libraries derived from a Homo sapiens proteome (THP1 cells) incubated with 
recombinant shewasin D or shewasin A at a ratio of 1:40 (enzyme/library). The analytical strategy applied was 
similar to that described in ref. 9. The average amino acid occurrences in P4–P4′ were calculated from one 
experiment for the trypsin library and two experiments for the GluC library and are shown in the form of two-
dimensional heatmaps of log(2) transformed values of fold-enrichment over natural abundance of amino acids 
(A,B) and % difference IceLogos (C,D). Both tryptic and GluC display consistency between them. In IceLogos 
representation, horizontal axis represents the amino acid position and vertical axis denotes the over- and 
under-representation of amino acid occurrence compared with the Swiss-Prot Homo sapiens protein database. 
Cysteines are carboxyamidomethylated and lysines are dimethylated.
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a differential sequence logo of the tryptic datasets, illustrating residues enriched or depleted at each position 
in shewasin D as compared to shewasin A (Fig. 3). As expected, the differences were rather small. Shewasin 
D showed a stronger preference for aromatic amino acids including phenylalanine at P1, whereas shewasin A 
cleaved more peptides with leucine at this position. In addition, shewasin D showed a preference for methionine 
and glutamate at P2 as well as for leucine at P3. At P4′ , peptides cleaved by shewasin D were slightly depleted 
in negatively charged amino acids when compared with shewasin A. Second, we explored subsite cooperativity 
between P3-P3′ positions11. No strong differences in subsite preference were observed when only the cleaved 
sequences with Leu at P1 were considered (data not shown). Fewer cleaved sequences with phenylalanine at P1′ 
contained leucine at P1 as compared to the whole dataset, but this effect was similar for both shewasin D and 
shewasin A (Supplementary Fig. S2A,B). Peptides with a branched valine at P2′ disfavored leucine at P1 slightly 
more for shewasin D than A (Supplementary Fig. S2C,D), but again the difference in selectivity was rather low. 
These results suggest that the selectivity of shewasins may likely extend beyond the P3–P3′ positions.
Subsite cooperativity was also explored to provide additional explanation to the observed differences in the 
catalytic efficiency between shewasins. A phenylalanine in P1 disfavored the presence of a bulky phenylalanine 
in P1′ in the shewasin A dataset (Supplementary Fig. S2E,F). Moreover, the simultaneous accommodation of 
phenylalanine residues by subsites S1 and S1′ may be facilitated by the presence of the glutamate residue in the 
P2 position of the substrate. For both shewasins, glutamate is more frequently found at P2 if P1′ is occupied by 
phenylalanine (Supplementary Fig. S2A,B) and vice versa Supplementary Fig. S2G,H). Taken together, these 
individual small differences in the active site structure may add up and produce the higher efficiency of shewasin 
D cleavage of the peptide (MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) at the Phe*Phe bond.
Native shewasin D is active and inhibited by pepstatin. We have shown clear evidence that the 
S. denitrificans pepsin homolog gene encodes for an active enzyme (with typical AP properties), thus corroborat-
ing previous work with its S. amazonensis ortholog5 and confirming that both bacterial gene sequences encode 
functional enzymes. However, the fact that the recombinant enzyme is active does not by itself prove its presence 
and activity in the original bacterial species. To further investigate whether shewasin D is expressed in vivo, we 
first confirmed the presence of transcripts by RT-PCR analysis (Supplementary Fig. S3) as well as protein expres-
sion in total extracts of S. denitrificans cells by Western blot analysis, which detected two bands migrating at an 
apparent MW of approximately 40 kDa and 50 kDa (Supplementary Fig. S4). We then attempted to purify native 
shewasin D by pepstatin-agarose affinity chromatography and again detected two bands with our shewasin D 
antibody (Supplementary Fig. S5). However, given the low yield of this purification method it was impossible to 
further separate the two forms. Next we implemented a different partial purification approach. A soluble protein 
extract prepared from overnight cultures was applied to an ion-exchange Mini Macro-Prep High Q Cartridge 
column (5 mL) (Bio Rad) and the eluted fractions were analyzed by Western blot with shewasin D specific anti-
body (Fig. 4A,B). The two reactive species were detected in the fractions eluted with a salt concentration between 
190 and 250 mM. Given the theoretical molecular weight of shewasin D (~46.7 kDa), these results suggested that 
either native shewasin D undergoes some proteolytic cleavage or that the lower molecular weight band may result 
from protein degradation. To further evaluate this finding these fractions were pooled and subjected to a second 
anion-exchange chromatography on a Mono Q column. The presence of shewasin D in eluted fractions was again 
confirmed through Western blot and followed by enzymatic activity assays at pH 4.0 with the fluorogenic peptide 
(MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP), shown to be cleaved by the recombinant enzyme. As 
Figure 3. Differential IceLogo representation of shewasin D versus shewasin A specificity profile using 
trypsin PICS library. The differential IceLogo represents the enriched and depleted residues for shewasin D 
(upper part of the IceLogo) using as reference set the peptides identified for shewasin A. Residues that are over- 
or under-represented in the experimental set are respectively shown in the top or bottom part of the IceLogo.
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illustrated in Fig. 4C,D, the eluted fraction displaying the highest activity towards this substrate showed a reactive 
band of ~ 40 kDa in the Western blotting, whereas lower enzymatic activity was observed in the fraction enriched 
in the 50 kDa species. These results appear to suggest that native shewasin D may likely occur in a processed as 
well as in a precursor (or autoinhibited form). To further confirm the nature of the observed enzymatic activity, 
this partially purified fraction enriched in the 40 kDa band was subsequently tested for activity in the presence of 
protease inhibitors. As expected, only pepstatin A had an inhibitory effect on this proteolytic activity (Fig. 4E). 
Moreover, the activity was assayed at pH 3.0, 3.5, and 4.0, and consistent with the results obtained with the 
Figure 4. Partial purification of native shewasin D. A soluble protein extract of S. denitrificans overnight 
cultures was prepared and subjected to two anion exchange chromatographic steps. (A) High Q chromatogram 
of soluble extract fractionation. Dotted lines delimit the fractions staining positive in the Western blot analysis 
with anti-shewasin D antibody. (B) Western blot analysis of samples 1 and 2 (panel A), with the anti-shewasin 
D antibody. (C) Mono Q chromatogram. Fractions 1 and 2 from (A) were pooled, diluted and subsequently 
applied to a Mono Q column. The enzymatic activity was tested towards the substrate (MCA)Lys-Lys-Pro-
Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) and is represented by a discontinuous line. (D) Western blot analysis 
of fractions 13–18 eluted from Mono Q (C) with anti-shewasin antibody. (E) Effect of protease inhibitors on 
the activity of partially purified fractions of native shewasin D. The effect of different compounds was tested 
by preincubating protein sample (fraction 13, panel C) with each inhibitor for 8 min at 37 °C. ****P < 0.0001 
compared with control using one-way ANOVA followed by Tukey’s post hoc test. (F) Effect of pH on the activity 
of partially purified fractions of native shewasin D. The assays were performed by incubating fraction 13 at 37 °C 
with buffers between pH 3.0 and 4.0. The error bars represent standard deviation of the mean.
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recombinant enzyme, fractions enriched in native shewasin D showed similar enzymatic activity when tested at 
pH 3.5 and pH 4.0, with a comparable decrease in activity at pH 3.0 (Fig. 4F).
Intracellular localization of native shewasin D. Next we determined the localization of shewasin D 
in S. denitrificans cells by immunogold labeling. The acquired immuno-electron microscopy (iEM) images of 
S. denitrificans bacteria showed sufficient morphological preservation to discern the double membrane bilayers 
(Fig. 5B, inset) and some intracellular structures. A distinct difference in the number of gold particles per bacte-
rium in the anti-shewasin D labeled sample (Fig. 5A,B) compared to the pre-immune serum control (Fig. 5E,F) 
was evident. The colloidal gold particles, 10 nm in diameter, were conjugated to Staphylococcal Protein A (sPA), 
with a length of approximately 5 nm. Since the primary antibodies are about 15 nm in length, the center of the col-
loidal gold particle can be localized up to 25 nm from the antigen to which it is interconnected. Although the gold 
particles appeared to preferentially accumulate in the vicinity of the lipid bilayers in the anti-shewasin D labeled 
samples, only a fraction of the gold particles were within a 25 nm radius from either the inner or outer membrane 
(Fig. 5C,D). These results suggest that the antigen accumulates in the cytoplasm, with only a subfraction of the 
antigen being localized to the membranes or the periplasm. Interestingly, the majority of gold particles overlaid 
the electron dense cytoplasmic areas, while localization to the lightly stained intracellular regions could seldom 
be observed. Only rarely could gold particles be found in the extracellular space, indicating that the antigen is 
not secreted.
Discussion
Pepsin homologs from bacteria have been identified through bioinformatics analysis1 but their enzymatic prop-
erties, native expression, intracellular localization, as well as structure-function relationships are still far from 
having been elucidated. Thus far, an enzymatic characterization has been provided for only shewasin A from 
S. amazonensis5. To gain further insights into this group of bacterial members of family A1 proteases we expanded 
our studies to the homolog from Gram-negative S. denitrificans, thereby named shewasin D. Shewasins A and 
D share 55% of amino acid sequence identity and are phylogenetically close to the eukaryotic aspartic proteases 
BACE-1 and BACE-21. Here we report the characterization of recombinant shewasin D and the first comprehen-
sive cleavage specificity profiles of both shewasin D and shewasin A. Moreover, our data provide the first experi-
mental evidence that shewasin D is expressed in vivo in S. denitrificans cells and demonstrate that it accumulates 
preferentially in the cytoplasm.
In general, enzymatic properties of recombinant shewasin D were shown to be very similar to those pre-
viously described for shewasin A and other pepsin-like APs. Like shewasin A, shewasin D was shown to be 
monomeric, to be specifically inhibited by pepstatin, to depend on an intact Asp-Asp catalytic dyad for pro-
teolytic activity, and to display maximum activity at acidic pH towards a substrate typically used to assess 
activity of APs, also hydrolyzing it between two hydrophobic residues. The optimal pH of shewasin D between 
pH 3.5 and 4.0 was slightly lower if compared to shewasin A, which is most active between pH 3.75–4.55. The 
temperature profile of recombinant shewasin D was shifted towards lower temperatures, with maximal activ-
ity detected at 30 °C to 37 °C, compared to 42 °C to 50 °C for shewasin A5, likely reflecting physiological char-
acteristics intrinsic to each Shewanella species12,13. However, the remarkable difference in activity towards 
(MCA)Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys(DNP) with specificity constants of 4.0 × 105 M−1. s−1 and 
5.6 × 103 M−1. s−1 5 for shewasin D and A, respectively, and the distinct preferences for the synthetic substrate 
(MCA)Lys-Leu-His-Pro-Glu-Val-Leu-Phe-Val-Leu-Glu-Lys(DNP), which was not cleaved by shewasin D, clearly 
point to differences in either the architecture or properties of their substrate-binding pockets.
To further explore specificity preferences of both proteases and compare them with their eukaryotic counter-
parts we determined P4–P4′ specificity profiles using PICS8. This type of proteomics analysis has been reported 
for HIV-1 protease9 and recently for the retropepsin-like APRc from Rickettsia6; however, to our knowledge, this 
is the first report on the use of this experimental approach for the characterization of pepsin-type AP specificity, 
as for these enzymes specificity studies have been essentially performed with individual substrates or using com-
binatorial peptide libraries14–20. Our data clearly confirmed common sequence preferences for both shewasins 
and eukaryotic pepsins. These include a strong preference for large hydrophobic amino acids such as leucine, 
phenylalanine, and tyrosine at P1 that is also described for pepsin, plasmepsins, cathepsins D and E, BACE1, 
cardosin A, and SAPs15–20. Also in agreement with what has been reported for most of these proteases14–17,19,20, the 
two β -branched hydrophobic amino acids isoleucine and valine as well as positively charged amino acids, neutral 
amino acids and proline were highly disfavored at this position for both shewasins. Interestingly, a strong pref-
erence for aspartate at P1 position was also noted in this study; however, aspartate might be protonated to a sig-
nificant degree and therefore neutral at the applied pH. The acceptance of aspartate at the S1 pocket was already 
observed for porcine pepsin14 as well as Sap 319, but with very low cleavage frequencies. A comparison of the 
putative amino acid residues in the S1 subsite in shewasins with those identified for porcine pepsin and BACE-
121,22 indicate some differences in the hydrophobicity of this subsite that might account for the higher preference 
of aspartate at P1 in shewasins. In line with what has been generally observed for pepsin-type proteases, the S1 
subsite is one of the most discriminating ones, and also much more stringent than S1′ subsite. Additionally, the 
trend to accept preferentially hydrophobic amino acids in P1′ is obvious in both shewasins16,17,19,20. However, we 
observed that bacterial proteases also accept amino acids with neutral side chains, such as asparagine, glutamine, 
and serine at this position. Regarding the observed preferences in positions distal to the scissile bond, shewasins’ 
S2 subsite was unveiled to be quite stringent with similar selectivity as the S1 subsite, except for isoleucine and 
valine which were shown to be accommodated in S2. The conserved preference for hydrophobic amino acids 
in P3 and for alanine and valine at P2′ positions are also common to pepsin, plasmepsins, and BACE-116,18,20. 
Interestingly, the pronounced lack of stringency in positions P3′ (and P4′ ) resembles what has been described for 
BACE-120, including the observation that P positions are in general more specific than P′ positions20. However, 
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the marked exclusion of asparagine from position P2 observed for both shewasins might explain the lack of 
activity towards BACE-1 substrate, since asparagine is one of the amino acids preferentially accommodated at 
this position by BACE-120. Although PICS is an end-point assay performed at high enzyme-to-substrate ratios 
and thus aggregates both kinetically preferred and very modest substrates in one profile, our observations that 
P1′ phenylalanine favors glutamate in P2 is in agreement with results obtained for plasmepsins when using a 
combinatorial library pool of fixed P1′ -Phe16, as well as for cathepsin D and pepsin18. Taken all together, our PICS 
Figure 5. Shewasin D is preferentially accumulated in the cytoplasm in Shewanella denitrificans. 
Representative iEM images of Shewanella denitrificans immunogold labeled using anti-shewasin D (1:200) as 
primary antibody (A–D) or pre-immune serum (1:16 000) (E,F). Both membranes (arrowheads), the periplasm 
between them as well as the gold particles (arrows) can be discerned (B). Gold particles within 25 nm from the 
membrane bilayers are encircled (C,D). The white spaces surrounding the cells correspond to bacterial capsules. 
Scale bar represents 2 μm (A,E), 1 μm (B,F), 100 nm (B, inset), 500 nm (C) and 200 nm (D).
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analysis provides clear indications that both shewasins share common traits with eukaryotic pepsin-type pro-
teases and further confirms the relevance of this experimental approach to help understanding both primary and 
secondary specificity determinants of these proteases. Nevertheless, our results also demonstrate that both shewa-
sins appear to be more stringent than most eukaryotic APs, sharing more similarities with BACE-1, as anticipated 
by the phylogenetic analysis. Determination of the three-dimensional structure of shewasin D or shewasin A will 
be essential for better understanding of the observed subtle differences and the influence of interacting amino 
acid residues in each subsite, not only for defining specificity but also their unexpected optimum acidic pH.
Indeed, our partial purification of native shewasin D confirmed activity at acidic pH values and inhibition by 
pepstatin, providing the evidence that the native enzyme appears to assume the behavior of a typical pepsin-like 
protease in vivo, as shown for the recombinant form. The observed higher enzymatic activity of an apparently pro-
teolytically processed form of native shewasin D further suggests that there might be additional regulatory mech-
anisms to control enzyme activity, likely compensating for the lack of the typical prosegment domain. Although 
further studies are required to understand the regulation of shewasin D activity and its function in vivo, the 
evidence reported herein on its predominant cytosolic localization is consistent with the lack of a signal peptide. 
Regulated proteolysis in bacteria has been gaining relevance in recent years as an important control mechanism 
of physiological processes and stress responses23. So far, bacterial proteases have been implicated in the regula-
tion of specific processes, such as cell division or methionine synthesis, as well as in global responses like protein 
quality control, SOS, heat or envelope stress responses23. However, it is likely that many proteolysis-dependent 
processes remain to be identified23, especially considering that some families of proteases have only recently 
been identified in Gram-negative bacteria, as is the case of aspartic proteases of both A1 and A2 families5,6,24. 
Proteolytic events are generally associated with fast responses in bacteria and, therefore, must be tightly regu-
lated. Our results showing the presence of two forms of shewasin D suggest that this protease may occur in a 
latent form in the cytoplasm that may be activated only under temporary local acidic conditions. Although we 
have been able to produce full-length shewasin D in E. coli in an active form, we cannot exclude the possibility 
that different regulatory mechanisms may indeed take place in S. denitrificans to maintain shewasin D in a latent 
form, as no homolog proteases are present in E. coli. Regulation of cytoplasmic pH in Gram-negative bacteria 
has been shown to be essential for their growth and survival, and acidification has been reported as a response 
to electrophilic stress25,26, hence shewasin D activation and activity may be tightly coupled with these changes in 
pH homeostasis and contribute to stress tolerance. Alternatively, we cannot rule out the secretion of shewasin D 
through a signal peptide-independent route, as suggested for other bacterial extracellular proteases27, that could 
also justify activation through processing upon secretion. The bacterial extracellular proteases reported so far 
play functions related to toxicity, virulence, or to nutrient acquisition and proliferation27–30, but again no detailed 
functional studies are yet available for bacterial pepsin-like proteases. The conservation in these genes together 
with their unusual pH optimum, indicates a unique kind of task these proteases have to fulfill and that is clearly 
worth being further uncovered.
Materials and Methods
Cloning of S. denitrificans gene encoding for shewasin D. The sequence encoding the pepsin homo-
logue gene of S. denitrificans (gene locus Sden_0804; sequence available at the EBI Data Bank under the accession 
number ABE54094.1) was optimized for codon usage in E. coli. The optimized gene was chemically synthesized 
(Genscript, Piscataway, NJ) with restriction sites for NdeI at the 5′ -end and XhoI at the 3′ -end, for subcloning in 
pET28a (Novagen, Gibbstown, USA) in frame with a N-terminal His-Tag. The active site mutant of shewasin D 
(D37A) was generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, USA) with the 
primers 5′ AAA GTG AAC CTG ATT ATT GCG ACC GGC AGC AGC ACC CTG 3′ (forward) and 5′ CAG GGT 
GCT GCT GCC GGT CGC AAT AAT CAG GTT CAC TTT 3′ (reverse) (mutation represented in bold). Both 
constructs were confirmed by DNA sequencing.
Expression and purification of recombinant shewasin D and active site mutant in E. coli. 
Wild-type shewasin D and active site mutant [shewasin D_D37A] constructs were transformed into E. coli 
C41(DE3) strain (Lucigen, WI, USA). In both cases gene expression was induced by 0.05 mM IPTG when the cul-
tures reached an OD600nm of 0.6–0.7, and protein expression was carried out overnight at 18 °C. After expression, 
cells were harvested by centrifugation at 8983 × g at 4 °C for 20 min and resuspended in 20 mM sodium phosphate 
buffer pH 7.5 with 10 mM imidazole and 0.5 M NaCl (binding buffer for IMAC). Lysozyme was added to a final 
concentration of 0.05 mg/mL and the final suspension was frozen. The same purification procedure was used for 
both wild type (wt) shewasin D and active-site mutant. Each suspension was thawed and DNase and MgCl2 were 
added to the final concentration of 0.05 mg/mL and 10 mM, respectively, and the reaction mixture was incubated 
for 2 h at 4 °C. Soluble and insoluble fractions were separated by centrifugation of the cell lysate at 12 000 × g for 
20 min. The soluble fraction obtained was filtered through 0.2 μm filters and immediately loaded on a HisTrapHP 
5 mL column (GE Healthcare Life Sciences, Uppsala, Sweden), charged with Co2+ ions (which was shown to be 
more efficient in eliminating lower molecular weight contaminants than an IMAC column loaded with Ni2+) and 
equilibrated in 20 mM sodium phosphate buffer pH 7.5 with 10 mM imidazole and 0.5 M NaCl (binding buffer). 
After sample loading, the column was connected to a chromatographic system (DuoFlow-BioRad, Hercules, 
USA) and extensively washed with binding buffer until the A280nm reached a steady baseline. Protein elution 
was performed with a stepwise gradient of imidazole concentration (50 mM, 100 mM and 500 mM), in the same 
buffer. Both proteins were eluted with buffer containing 100 mM imidazole. Fractions were pooled, concen-
trated (Amicon Ultra Centrifugal Filter Unit, Millipore) and applied to a size exclusion chromatography HiLoad 
26/60 Superdex 200 prep grade column (GE Healthcare Life Sciences), pre-equilibrated in 20 mM Tris-HCl pH 
8.0 buffer with 150 mM NaCl. Shewasin D and active site mutant containing fractions were further purified by 
ion exchange chromatography in a Mono Q 5/50 (GE Healthcare Life Sciences) connected to an FPLC system 
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(DuoFlow-BioRad, Hercules, USA). Protein elution was carried out with a linear gradient of NaCl (0–1 M) in 
20 mM Tris-HCl pH 8.0 buffer.
Size-exclusion chromatography. The molecular masses of purified active recombinant shewasin D and 
shewasin D_D37A were evaluated by size-exclusion chromatography under non-denaturing conditions on a 
Superose 12 (GE Healthcare Life Sciences) column equilibrated with 20 mM Tris-HCl buffer pH 8.0 with 150 mM 
NaCl in a DuoFlow-BioRad FPLC system. The column was calibrated with Gel Filtration HMW and LMW cali-
bration kits (GE Healthcare Life Sciences), using as molecular mass markers aldolase (158 kDa), conalbumin 
(75 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and ribonuclease A (13.7 kDa).
Enzyme assays. The proteolytic activity of purified recombinant shewasin D was determined 
with several fluorogenic protease substrates: [(7-methoxycoumarin-4-yl)acetyl(MCA)-Lys]-Lys-P
ro-Ala-Glu-Phe-Phe-Ala-Leu-[Lys-2,4-Dinitrophenyl (DNP)] (GenScript, Piscataway, USA), [MCA-Lys]- 
Leu-His-Pro-Glu-Val-Leu-Phe-Val-Leu-Glu-[Lys-DNP] (Genosphere Biotechnologies), [MCA-Lys]-Ala-Leu- 
Ile-Pro-Ser-Tyr-Lys-Trp-Ser-[Lys-DNP] (GenScript, Piscataway, USA), the renin substrate Arg-Glu 
(5-[(2-aminoethyl)amino]naphthalene - 1 - sulfonic acid (EDANS)-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys 
(4- (dimethylaminoazo) benzene-4-carboxylic acid (DABCYL)-Arg (Sigma) and BACE-1 substrate [MCA-Lys]- 
Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-[Lys-DNP] (Genosphere Biotechnologies). Excitation and emission 
wavelengths of 328 nm and 393 nm, respectively, were used to monitor the rate of hydrolysis of the substrates, 
except for the renin substrate where an excitation wavelength of 340 nm and emission wavelength of 490 nm 
was used. The total fluorescence change that occurred upon complete hydrolysis of the substrate was used to 
determine the relationship between fluorescence change and substrate concentration. Of all the substrates listed 
above, only [(MCA)-Lys]-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-[Lys(DNP)] was found to be cleaved by recombi-
nant shewasin D. Kinetic parameters for the cleavage of this substrate were calculated from the Lineweaver–Burk 
plot with appropriate software. For activity studies at different pH values (at 37 °C), the following buffers with 
pH values between 2.5 and 5.5 were used: 0.05 M sodium citrate (pH 2.5–3.5) and 0.05 M sodium acetate (pH 
4–5.5), all containing 0.1 M NaCl. To assess activity of recombinant shewasin D at different temperatures, the 
proteolytic activity was determined after pre-incubation of the enzyme in 0.05 M sodium acetate buffer pH 4.0 
with 0.1 M NaCl at temperatures between 5 °C and 50 °C, for 8 min. The effect of various protease inhibitors 
on proteolytic activity was evaluated by pre-incubating the enzyme with each compound at 37 °C, in 0.05 M 
sodium acetate buffer pH 4.0 with 0.1 M NaCl for 8 min, before determination of proteolytic activity. The rate 
of hydrolysis of the substrate was monitored for 600 seconds. Statistical analysis was performed by a one-way 
analysis of variance (ANOVA) followed by post hoc multiple comparisons using Tukey’s test. A P-value < 0.05 
was taken as statistically significant. Shewasin D_D37A was tested for activity under the same assay conditions. 
Partially purified samples containing native shewasin D (see below) were assayed for activity towards [(MCA)- 
Lys]-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-[Lys(DNP)] at 37 °C, in 0.05 M sodium acetate buffer (pH 3–4) with 
0.1 M NaCl. The effect of protease inhibitors was assayed under similar conditions as those described for recom-
binant shewasin D.
RT-PCR analysis. S. denitrificans strain was obtained from the collection of the Centre de Ressources 
Biologiques de l′ Institut Pasteur (CRBIP) (code 107825), and propagated under the following conditions: Difco 
Marine Broth (BD) (55.1 g/L) pH 7.6, agar (when needed) (15 g/L) at 30 °C. Total RNA was isolated from 1 mL 
of S. denitrificans culture using TRIzol (Invitrogen). The quality and integrity of the extracted total RNA was 
evaluated on 1% agarose gel electrophoresis. Total RNA sample was then treated with DNase (RNase Free, 
New England BioLabs) before cDNA synthesis. 1 μg of DNA-free RNA was used as template in the synthesis of 
single-stranded cDNA with the 1st Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche Applied Science) 
using the specific primer for shewasin D 3′ -end: 5′ TCA TGA TTT TTG CCT ATG GGC 3′. In parallel, a negative 
control was performed where the reverse transcriptase was excluded from the reaction mixture. The resulting 
products of the single-stranded cDNA synthesis and negative control were then used as templates in PCR ampli-
fication using HotMaster Taq DNA Polymerase (5Prime) and the specific primers for S. denitrificans shewasin 
D gene (5′ CTA CCC AGC GCC CTT GAG G 3′ as the forward primer and again 5′ TCA TGA TTT TTG CCT 
ATG GGC 3′ as the reverse primer). The amplification conditions were as follows: 95 °C for 5 min followed by 
30 cycles of 95 °C for 35 s, 58 °C for 50 s and 68 °C for 1 min. A negative control of the PCR amplification was 
performed where no cDNA template was added. The results of the RT-PCR were evaluated on a 1% agarose elec-
trophoresis gel stained with ethidium bromide. The amplified product, that should correspond to the last 486 bp 
of the coding sequence of shewasin D, was purified (NZYGelpure, NZYtech), cloned, and both strands were 
sequenced by automated DNA sequencing.
Partial purification of native shewasin D. A S. denitrificans culture was grown in a final volume of 2 L of 
Marine broth pH 7.6 at 30 °C for 16 h. The culture was then harvested by centrifugation, resuspended in 0.02 M 
Tris-HCl buffer pH 8.0 and the cell suspension lysed with three passages through an EmulsiFlex (AVESTIN, 
Inc.) (10000 psi). The soluble fraction separated by centrifugation (186000 × g, for 20 min) was then applied 
to a High Q column (Bio-Scale Mini, UNOsphere Q Cartridge, 5 mL, BioRad) connected to an FPLC system 
(DuoFlow-BioRad, Hercules, USA). Protein elution was carried out with a linear gradient of NaCl (0–1 M) in 
0.02 M Tris-HCl buffer pH 8.0 buffer at 2 mL/min. Fractions that were immunostained with the anti-shewasin D 
antibody (GenScript, Piscataway, USA) were pooled, diluted and applied to a Mono Q 5/50 (GE Healthcare Life 
Sciences) connected to an FPLC system (DuoFlow-BioRad, Hercules, USA). Protein elution was carried out with 
a linear gradient of NaCl (0–1 M) in 20 mM Tris-HCl buffer pH 8.0.
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Immunogold labeling. Determination of the intracellular localization of shewasin D in S. denitrificans 
was performed by Vironova AB (Stockholm, Sweden) using the Tokuyasu method. The formaldehyde fixed (3% 
formaldehyde in a 0.1 M phosphate buffer, pH 7.4) S. denitrificans bacteria were embedded in gelatine, infil-
trated with sucrose for cryoprotection, and frozen by immersion in liquid nitrogen. Ultrathin sections were pre-
pared using a cryo-ultramicrotome under cryo conditions (–120 °C) and sections were transferred to nickel/
formvar grids. Unspecific antibody binding was blocked by incubating the sections twice in 0.1 M cacodylate 
buffer containing 2% bovine serum albumin (BSA) and 2% gelatine. The samples were subsequently immuno-
labeled overnight with an anti-shewasin D antibody (diluted 1:200 to a final protein concentration of 2.5 μg/ml) 
or pre-immune serum (diluted 1:16000 to a final protein concentration of 2.7 μg/ml) diluted in 0.1 M cacodylate 
buffer containing 0.5% BSA and 0.2% gelatin. Staphylococcal Protein A (sPA) conjugated with 10 nm colloidal 
gold particles was used as the secondary probe. The samples were incubated with sPA-Au diluted 1:100 for 2 h and 
post-fixed with 2% glutaraldehyde. Finally, specimen contrast was enhanced using 0.05% uranyl acetate stabilized 
with 1% methylcellulose and the samples were analyzed using a FEI Tecnai 12 Biotwin transmission electron 
microscope. Images were acquired using a 2kx2k Veleta CCD camera (Olympus Soft Imaging Solution). Distance 
measurements were carried out using the Vironova Analyzer® software.
Proteomic identification of protease cleavage sites (PICS). Recombinant shewasin D and shewasin 
A5 specificity profiling was determined by PICS methodology as described in reference9, with minor changes. 
Proteome-derived peptide libraries were generated by digest of THP-1 cells lysates with trypsin or GluC. 
Both libraries were independently incubated with purified recombinant shewasin D or shewasin A in 50 mM 
sodium acetate buffer pH 4.0 supplemented with 100 mM NaCl at protease-to-library ratios of 1:40 (w/w), for 
six h at 37 °C. Reactions were stopped by addition of 1 μM pepstatin. Carboxy-terminal peptide cleavage prod-
ucts enriched by biotinylation and streptavidin-mediated pullout, were separated on a HALOTM C18 column 
(Eksigent) connected to a TripleTOF 5600 (AB SCIEX). Peptide sequences were identified with X!Tandem31, in 
conjunction with IProphet32 at a confidence level > 99%. Search parameters included mass tolerances of 0.05 Da 
for parent ions and 0.1 Da for fragment ions and the following static modifications: carboxyamidomethylation 
of cysteine residues (+ 57.02 Da), dimethylation of lysines (+ 28.03 Da) and thioacylation of peptide amino 
termini (+ 88.00 Da). Semi-style cleavage searches were applied with no constraints for the orientation of the 
specific terminus. The Web-based PICS service9 was used for inference of nonprime sequences and recon-
struction of the cleavage sites. Sequence logos were generated with IceLogo33, shown are significant differences 
in amino acid occurrence at each position as compared to the expected amino acid frequency in the human 
proteome-derived peptide libraries (p-value of 5%). The mass spectrometry proteomics data have been depos-
ited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner 
repository34 with the dataset identifier PXD003078.
SDS-PAGE and Immunoblotting. Protein samples were analyzed by SDS-PAGE using 12% gels and the 
Mini Protean III electrophoresis apparatus (Bio-Rad, Hercules, CA, USA). Gels were stained with Coomassie 
Brilliant Blue R-250 (Sigma). For immunoblotting analysis, protein samples were separated by SDS-PAGE (12% 
gels) and transferred to a polyvinylidene difluoride membrane (40 V, overnight at 11 °C) in 25 mM Tris and 
192 mM Glycine buffer, with 20% methanol using a Trans Blot Electrophoretic Transfer Cell (Bio-Rad, Hercules, 
CA, USA). The membranes were blocked for 60 min with 5% (w/v) nonfat dry milk plus 0.1% (v/v) Tween-20 in 
10 mM Tris pH 8.0 with 150 mM NaCl, and then incubated with the primary antibody for 60 min. Primary anti-
bodies used were mouse anti-His-tag antibody (GenScript; 1:10000 dilution), and rabbit anti-shewasin D anti-
body (specifically raised towards the sequence Ala-Asn-Met-Thr-Pro-Glu-Ser-Leu-Ala-Leu-Asp-Pro-Leu-Asn, 
amino acids 208–221) (GenScript; 1:10000 dilution). After several washes with 0.5% (w/v) nonfat dry milk plus 
0.1% (v/v) Tween-20 in 10 mM Tris and 150 mM NaCl pH 8.0, the membranes were incubated for 60 min with 
the secondary antibody: [alkaline phosphatase-conjugated goat anti-(mouse IgG + IgM)(GE Healthcare; 1:10 000 
dilution) or [alkaline phosphatase-conjugated goat anti-(rabbit IgG + IgM)(GE Healthcare; 1:10 000 dilution). 
The membranes were again washed and alkaline phosphatase activity was visualized using ECF (GE Healthcare) 
on a Molecular Imager FX (Bio-Rad).
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